These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 6083292

  • 21. [Cliical aspects of cardiocinetic therapy with a new cardioactive glucoside: acetyldigoxin].
    Malaguti P.
    Minerva Cardioangiol; 1968 Mar; 16(3):225-30. PubMed ID: 5740756
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Study of the activity of a cardioactive glucoside, proscillaridin A, in ambulatory patients].
    Parenti B, Cavasonza G.
    Minerva Cardioangiol; 1971 Jul; 19(7):376-83. PubMed ID: 5106123
    [No Abstract] [Full Text] [Related]

  • 26. [Preliminary clinical experences and therapeutic use of a new cardioactive glycoside (Stellarid)].
    Messina D.
    Minerva Med; 1967 Dec 01; 58(96):4289-96. PubMed ID: 6083291
    [No Abstract] [Full Text] [Related]

  • 27. [Trial of a combination of proscillaridin A, thioridazine and Cori ester in the ambulatory treatment of some cardiopathies, especially senile types].
    Bellardo G, Pichierri U.
    Minerva Med; 1976 Sep 30; 67(46):2985-90. PubMed ID: 967364
    [Abstract] [Full Text] [Related]

  • 28. [Dangers of rapid digitalization].
    Fiehring H, Assmann I, Haustein KO.
    Z Gesamte Inn Med; 1979 Oct 15; 34(20):suppl 273-6. PubMed ID: 95071
    [Abstract] [Full Text] [Related]

  • 29. [Effect of cardiac glycosides on the duration of systole. A comparison between proscillaridin and strophanthin].
    Heierli C, Schweizer W, Burkart F.
    Schweiz Med Wochenschr; 1971 May 08; 101(18):638-42. PubMed ID: 5103642
    [No Abstract] [Full Text] [Related]

  • 30. [Cardiac glycoside therapy].
    Born H.
    Folia Clin Int (Barc); 1969 Nov 08; 17(11):534-45. PubMed ID: 5803723
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Indications, contraindications, and nonindications for digitalis therapy.
    Duca P, Brest AN.
    Cardiovasc Clin; 1974 Nov 08; 6(2):131-40. PubMed ID: 4613456
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Report on the clinical test of peruvoside].
    Schwind K.
    Med Welt; 1969 Jan 18; 3():134-42. PubMed ID: 5764799
    [No Abstract] [Full Text] [Related]

  • 36. [The antiarrhythmic and coronary-dilating properties of verapamil in patients ith ischemic heart disease].
    Votcal BE, Lozinskij LG, Goldberg VA, Venediktova MG, Gribova OA.
    Arzneimittelforschung; 1970 Sep 18; 20():Suppl 9a:1281+. PubMed ID: 5312386
    [No Abstract] [Full Text] [Related]

  • 37. The current status of digitalis therapy.
    Chung EK.
    Mod Treat; 1971 Aug 18; 8(3):643-714. PubMed ID: 4941273
    [No Abstract] [Full Text] [Related]

  • 38. [Action of oral proscillaridin treatment in various forms of heart insufficiency].
    Muth HW, Weyer H.
    Med Welt; 1965 Dec 18; 51():2883-6. PubMed ID: 5884860
    [No Abstract] [Full Text] [Related]

  • 39. [Clinical aspects of the aging heart].
    Bender F.
    Z Kardiol; 1985 Dec 18; 74 Suppl 7():49-54. PubMed ID: 4090588
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.